Nasus Pharma (NYSEAMERICAN:NSRX) Shares Up 1.8% – What’s Next?

Nasus Pharma Ltd. (NYSEAMERICAN:NSRX)’s share price shot up 1.8% during trading on Thursday . The company traded as high as $2.31 and last traded at $2.25. 44,976 shares traded hands during mid-day trading, a decline of 22% from the average session volume of 57,792 shares. The stock had previously closed at $2.21.

Analysts Set New Price Targets

Separately, Citizens Jmp decreased their price target on Nasus Pharma from $19.00 to $18.00 and set a “market outperform” rating on the stock in a research note on Thursday, March 26th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $18.00.

Nasus Pharma Stock Up 1.8%

The stock’s fifty day moving average price is $3.84.

About Nasus Pharma

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.